Affiliations: Hospital Universitario Central de Asturias
Correspondence:
[*]
Corresponding author: Manuel Menendez-Gonzalez, Hospital Universitario Central de Asturias, Secretaria de Neurologia, C/Julian Claveria s/n, 33006, Oviedo, Spain. Tel.: +34985108000; Ext: 36206; Fax: +34985109430; E-mail: manuelmenendez@gmail.com.
Note: [] Communicated by Marwan Sabbagh
Abstract: Introduction:Lewy body dementia (DLB) is common but frequently misdiagnosed as Alzheimer’s disease plus delirium or parkinsonism. Drugs used in this disorder can cause exacerbations: neuroleptic medication is relatively contraindicated because some patients show severe neuroleptic sensitivity, antiparkinsonian medication has the potential to exacerbate psychotic symptoms, and even cholinesterase inhibitors, while relatively safe, have provoked adverse responses in some DLB patients. There are few data available about the use of memantine in DLB. Case presentation:A 74-year-old man was diagnosed with Alzheimer disease and parkinsonism. After memantine was started he developed severe fluctuations in awareness, visual hallucinations, agitation, and worsened parkinsonism. When he was evaluated thoroughly, the diagnosis was revised to Lewy body dementia, leading to changes in treatment that were associated with dramatic improvement in the patient’s mental status. Conclusions:In our patient, motor and cognitive symptoms worsened with memantine treatment; these resolved after memantine was discontinued.
